SCHEMBL13601119

SCHEMBL13601119

N#CC[C@@H]1CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7019193 0.82
SCHEMBL13832681 0.82
SCHEMBL13832621 0.82
SCHEMBL3941101 0.80
Hydrochloric Acid SCHEMBL13740079 0.80
SCHEMBL22720088 0.80
Hydrochloric Acid SCHEMBL13739242 0.80
Hydrochloric Acid SCHEMBL13739243 0.80
Trifluoroacetic Acid SCHEMBL35211020 0.80 CHRNB2 (0.35)
SCHEMBL5225497 0.79 CYP2D6 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392683-B1 SUBSTITUTED 4H-CHROMENES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THEIR USE AS ANTICANCER AGENTS CYTOVIA INC (US) 2009-12-02 EP disclosed